Monday 18th June 2012
|Text too small?
Nuplex Industries, the specialty chemicals maker, raised US$105 million by tapping the US private placement market and will use the funds to refinance a facility used to acquire Viverso last year.
The notes mature in 2019 and carry a coupon of 6.125 percent, the Auckland-based company said in a statement. The US dollar proceeds will be converted into euros via a cross currency swap.
Nuplex lifted its debt facilities by about A$100 million to A$300 million to finance the acquisition after agreeing to buy Bayer MaterialScience's Viverso for 75 million euros in October, adding resins production in Germany.
The company also said it will redeem its $52.6 million of capital notes on Sept. 15, using funds from existing bank facilities. Following the redemption, Nuplex's total debt facilities will be the US$105 million of notes and the existing A$200 million bank facilities.
"By raising funds in the USPP market we have been able to access long term, fixed price debt which balances and strengthens our overall funding position by extending our maturity profile and diversifying our funding sources," said chief financial officer Ian Davis.
Shares of Nuplex were unchanged at $2.54 and have gained 11 percent this year. The stock is rated ‘hold' based on the consensus of six analysts polled by Reuters.
No comments yet
Nuplex targets half billion dollar Asian sales within five years
Nuplex FY profit drops 31 percent on weak ANZ, EMEA markets, writedowns
Nuplex cuts FY guidance again as Australian manufacturing splutters; stock drops
Nuplex 1H profit misses forecasts; annual guidance cut on strong kiwi, weak trading conditions
Nuplex looks at imputing future dividends, flags increased earnings
Nuplex plans restructuring in Australia, NZ to cut 2013 profit
Nuplex FY profit falls, guidance met
Nuplex sees full-year earnings at bottom of range
Nuplex 1H profit drops 23% on Australasian weakness
Nuplex enters Russian joint venture